A new observational study investigating cannabis cognitive effects in HIV patients addresses critical knowledge gaps in medical marijuana guidance. This research could establish therapeutic windows and safety profiles for cannabis use in HIV populations. The trial’s findings may fundamentally change evidence-based cannabis recommendations for cognitive health in HIV care.
Judge Takes CMS HEMP-MARIJUANA CBD Program Under Advisement – The Globe and Mail
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchPolicyCBDClinical TrialsFDA Approval Why This Matters # ResponseA federal judge's review of the CMS HEMP-MARIJUANA...
The effects of cannabidiol on sleep disturbances within a sample of high trait worriers: A double-blind, randomized placebo controlled trial.
A new double-blind, placebo-controlled trial found that CBD showed no significant benefit over placebo for sleep disturbances in adults with high worry levels. This rigorous study challenges popular assumptions about CBD’s effectiveness for sleep and highlights the importance of evidence-based cannabis medicine. The negative findings provide crucial data for clinicians counseling patients about realistic expectations for CBD sleep products.
. @crescolabs CEO: Rescheduling Ushers in a New Era of Medical Cannabis Patient Care –
✦ New CED Clinical Relevance #74Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyResearchMedical CannabisRegulationClinical Trials Why This Matters Rescheduling cannabis from Schedule I to Schedule III...
“Today we can start medical research in the USA on Cannabis … This is part of the continuing …
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic ResearchFederal PolicyClinical TrialsEvidence-Based MedicineRegulatory Why This Matters The opening of federally-compliant cannabis research infrastructure...
Cannabinoid Clinical Trials: Anxiety & Tourette Syndrome
Clinical Takeaway CBD shows modest evidence for reducing acute anxiety symptoms in some clinical settings, while THC-dominant formulations may increase anxiety and are not recommended for anxiety disorders. Current evidence is insufficient...
Federal government reclassifying medical marijuana – YouTube
✦ New CED Clinical Relevance #88High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic PolicyResearchFederal RegulationClinical TrialsMedical Cannabis Why This Matters Federal reclassification of cannabis from Schedule...
Federal reclassification of medical marijuana opens new research doors for Colorado scientists
✦ New CED Clinical Relevance #88High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic ResearchPolicyEvidence-Based MedicineClinical TrialsRegulation Why This Matters Federal reclassification from Schedule I to Schedule...
Cannabinoid Clinical Trials for Anxiety and Tourette
Clinical Takeaway CBD demonstrates efficacy for generalized anxiety disorder and social anxiety disorder with favorable safety profiles, while THC-dominant formulations show mixed results with potential anxiety-worsening effects at higher doses. Current evidence...
Federal reclassification of medical marijuana opens new research doors for Colorado scientists
✦ New CED Clinical Relevance #88High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic ResearchPolicyClinical TrialsEvidence-Based MedicineRegulatory Why This Matters Federal reclassification from Schedule I to Schedule...